{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:56Z","timestamp":1791928676782,"version":"4.3.4"},"reference-count":153,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Transactive response DNA-binding protein of 43 kDa (TDP-43) and tau proteins play critical roles in neurodegenerative diseases, particularly frontotemporal lobar degeneration (FTLD) and Alzheimer\u2019s disease (AD). The co-occurrence of TDP-43 and tau pathologies raises questions about their role in disease progression. This review explores the simultaneous presence of tau and TDP-43 co-pathologies, emphasizing their molecular interactions and the resultant neuropathological implications. Additionally, we provide representative examples of their clinical presentations, neuroimaging, and neuropathological findings associated with FTLD-TDP and FTLD-tau, emphasizing the need for a comprehensive understanding of these intertwined pathologies. We analyze various clinical scenarios, including argyrophilic grain disease (AGD), primary age-related tauopathy (PART), and limbic predominant age-related TDP-43 encephalopathy (LATE), to elucidate the complex relationship between these proteinopathies. From the literature, the co-occurrence of tau and TDP-43 is linked to more severe and poorer clinical outcomes compared to isolated pathologies. This review underscores the necessity of considering co-pathologies in the context of FTLD, as they may act as accelerators of cognitive decline. This highlights the importance of integrated approaches in diagnosing and treating neurodegenerative conditions characterized by tau and TDP-43 misfolding. Understanding the interplay between these molecular markers is vital for advancing therapeutic strategies for such disorders.<\/jats:p>","DOI":"10.3390\/brainsci15070716","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T09:57:39Z","timestamp":1751536659000},"page":"716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Looking into Abnormal Co-Expressions of Tau and TDP-43 in the Realm of Mixed Dementia Types: A Double-Punch Scenario"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8876-8038","authenticated-orcid":false,"given":"Hossam","family":"Youssef","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7196-5390","authenticated-orcid":false,"given":"Carina","family":"Weissmann","sequence":"additional","affiliation":[{"name":"Institute of Physiology, Molecular Biology and Neuroscience, Buenos Aires C1428EGA, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8706-9443","authenticated-orcid":false,"given":"Gokhan","family":"Uruk","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2170-6662","authenticated-orcid":false,"given":"Rodolfo Gabriel","family":"Gatto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnen\/nly018","article-title":"Combined Pathologies in FTLD-TDP Types A and C","volume":"77","author":"Gefen","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s11357-021-00407-0","article-title":"Tau and TDP-43 synergy: A novel therapeutic target for sporadic late-onset Alzheimer\u2019s disease","volume":"43","author":"Latimer","year":"2021","journal-title":"Geroscience"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 Pathology in Alzheimer\u2019s Disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnen\/nlae032","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis","volume":"83","author":"Nelson","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/21678421.2020.1733019","article-title":"Mixed neuropathology in frontotemporal lobar degeneration","volume":"21","author":"Pennington","year":"2020","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-023-00653-0","article-title":"TDP-43 pathology is associated with increased tau burdens and seeding","volume":"18","author":"Tome","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-020-00934-5","article-title":"Distinct molecular patterns of TDP-43 pathology in Alzheimer\u2019s disease: Relationship with clinical phenotypes","volume":"8","author":"Tome","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jalz.2019.03.003","article-title":"Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa","volume":"15","author":"Josephs","year":"2019","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., and Ishigaki, S. (2022). TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415755"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3233\/JAD-240136","article-title":"TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy","volume":"99","author":"Youssef","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/nan.12664","article-title":"Concomitant LATE-NC in Alzheimer\u2019s disease is not associated with increased tau or amyloid-beta pathological burden","volume":"46","author":"McAleese","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/brain\/awac091","article-title":"Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration","volume":"145","author":"Riku","year":"2022","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13213","DOI":"10.1111\/bpa.13213","article-title":"LATE-NC in Alzheimer\u2019s disease: Molecular aspects and synergies","volume":"34","author":"Tome","year":"2024","journal-title":"Brain Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","article-title":"Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: A clinico-imaging-pathological study of primary age-related tauopathy (PART)","volume":"133","author":"Josephs","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000304041.09418.b1","article-title":"Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype","volume":"70","author":"Josephs","year":"2008","journal-title":"Neurology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26711","article-title":"When Alzheimer\u2019s is LATE: Why Does it Matter?","volume":"94","author":"Nelson","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jiang, L.L., Zhang, X.L., and Hu, H.Y. (2024). Co-Aggregation of TDP-43 with Other Pathogenic Proteins and Their Co-Pathologies in Neurodegenerative Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212380"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Youssef, H., Gatto, R.G., Pham, N.T.T., Jones, D., Petersen, R.C., Machulda, M.M., Whitwell, J.L., and Josephs, K.A. (2025). Multiple Neuropathologies Underly Hippocampal Subfield Atrophy in a Case With a Slowly Progressive Amnestic Syndrome: Challenging the Notion of Pure LATE-NC. Neuropathology.","DOI":"10.1111\/neup.70000"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1111\/ene.15048","article-title":"Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review","volume":"28","author":"Dulski","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1111\/j.1742-4658.2011.08256.x","article-title":"TDP-43: The relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration","volume":"278","author":"Baloh","year":"2011","journal-title":"Febs J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn.2778","article-title":"Characterizing the RNA targets and position-dependent splicing regulation by TDP-43","volume":"14","author":"Tollervey","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/rna.7.4.12205","article-title":"The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation","volume":"7","author":"Buratti","year":"2010","journal-title":"RNA Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuron.2017.02.046","article-title":"Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31","volume":"94","author":"Ishiguro","year":"2017","journal-title":"Neuron"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ma, X., Ying, Y., Xie, H., Liu, X., Wang, X., and Li, J. (2021). The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.755096"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/pr901076y","article-title":"Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery","volume":"9","author":"Freibaum","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1074\/jbc.M110.166587","article-title":"TDP-43 is a transcriptional repressor: The testis-specific mouse acrv1 gene is a TDP-43 target in vivo","volume":"286","author":"Lalmansingh","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1523\/JNEUROSCI.0536-20.2020","article-title":"Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling","volume":"40","author":"Dutta","year":"2020","journal-title":"J. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"102459","DOI":"10.1016\/j.isci.2021.102459","article-title":"Molecular, functional, and pathological aspects of TDP-43 fragmentation","volume":"24","author":"Chhangani","year":"2021","journal-title":"iScience"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/ncomms5824","article-title":"Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients","volume":"5","author":"Fang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16208","DOI":"10.1523\/JNEUROSCI.2911-10.2010","article-title":"Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy","volume":"30","author":"Liachko","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-030-51140-1_13","article-title":"Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance","volume":"1281","author":"Neumann","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","article-title":"The basis of clinicopathological heterogeneity in TDP-43 proteinopathy","volume":"138","author":"Kawakami","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Barbier, P., Zejneli, O., Martinho, M., Lasorsa, A., Belle, V., Smet-Nocca, C., Tsvetkov, P.O., Devred, F., and Landrieu, I. (2019). Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00204"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e202400180","DOI":"10.1002\/cmdc.202400180","article-title":"Tau Protein and Tauopathies: Exploring Tau Protein\u2013Protein and Microtubule Interactions, Cross-Interactions and Therapeutic Strategies","volume":"19","year":"2024","journal-title":"ChemMedChem"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1523\/JNEUROSCI.3129-20.2021","article-title":"Regulation of Synapse Weakening through Interactions of the Microtubule Associated Protein Tau with PACSIN1","volume":"41","author":"Regan","year":"2021","journal-title":"J. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s40478-021-01246-y","article-title":"Synaptic tau: A pathological or physiological phenomenon?","volume":"9","author":"Robbins","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cm.21820","article-title":"Tau here, tau there, tau almost everywhere: Clarifying the distribution of tau in the adult CNS","volume":"81","author":"Kanaan","year":"2024","journal-title":"Cytoskelet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s40478-023-01702-x","article-title":"Nuclear face of Tau: An inside player in neurodegeneration","volume":"11","author":"Younas","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2017.09.030","article-title":"Aging dependent effect of nuclear tau","volume":"1677","author":"Gil","year":"2017","journal-title":"Brain Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuroscience.2018.01.002","article-title":"Tau Deficiency Down-Regulated Transcription Factor Orthodenticle Homeobox 2 Expression in the Dopaminergic Neurons in Ventral Tegmental Area and Caused No Obvious Motor Deficits in Mice","volume":"373","author":"Tang","year":"2018","journal-title":"Neuroscience"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bukar Maina, M., Al-Hilaly, Y.K., and Serpell, L.C. (2016). Nuclear Tau and Its Potential Role in Alzheimer\u2019s Disease. Biomolecules, 6.","DOI":"10.3390\/biom6010009"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Corsi, A., Bombieri, C., Valenti, M.T., and Romanelli, M.G. (2022). Tau Isoforms: Gaining Insight into MAPT Alternative Splicing. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315383"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-3-8","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"3","author":"Liu","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10626","DOI":"10.1021\/bi00158a027","article-title":"Structure and novel exons of the human tau gene","volume":"31","author":"Andreadis","year":"1992","journal-title":"Biochemistry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","article-title":"Glial and neuronal tau pathology in tauopathies: Characterization of disease-specific phenotypes and tau pathology progression","volume":"73","author":"Ferrer","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_50","first-page":"43","article-title":"Glial Tau Pathology in Tauopathies: Functional Consequences","volume":"9","author":"Kahlson","year":"2015","journal-title":"J. Exp. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40478-024-01745-8","article-title":"Astrocytic accumulation of tau fibrils isolated from Alzheimer\u2019s disease brains induces inflammation, cell-to-cell propagation and neuronal impairment","volume":"12","author":"Eltom","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","article-title":"Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau)","volume":"45","author":"Dickson","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gatto, R.G., Carlos, A.F., Reichard, R.R., Lowe, V.J., Whitwell, J.L., and Josephs, K.A. (2023). Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer\u2019s & frontotemporal lobar degeneration patients. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0284182"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1002\/alz.14330","article-title":"Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions","volume":"20","author":"Gatto","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","article-title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","volume":"30","author":"Chatterjee","year":"2024","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41374-019-0196-y","article-title":"Tau and TDP-43 proteinopathies: Kindred pathologic cascades and genetic pleiotropy","volume":"99","author":"Chornenkyy","year":"2019","journal-title":"Lab. Invest."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-018-0237-9","article-title":"Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration","volume":"13","author":"Taylor","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Liachko, N.F., McMillan, P.J., Strovas, T.J., Loomis, E., Greenup, L., Murrell, J.R., Ghetti, B., Raskind, M.A., Montine, T.J., and Bird, T.D. (2014). The tau tubulin kinases TTBK1\/2 promote accumulation of pathological TDP-43. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004803"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Koga, S., Zhou, X., Murakami, A., Fernandez De Castro, C., Baker, M.C., Rademakers, R., and Dickson, D.W. (2022). Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology. Neuropathol. Appl. Neurobiol., 48.","DOI":"10.1111\/nan.12778"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00415-018-9086-2","article-title":"Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: Nine case series","volume":"265","author":"Kim","year":"2018","journal-title":"J. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/nan.12155","article-title":"No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease","volume":"40","author":"Robinson","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1093\/nar\/gkx175","article-title":"TDP-43 suppresses tau expression via promoting its mRNA instability","volume":"45","author":"Gu","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10600","DOI":"10.1074\/jbc.M117.783498","article-title":"Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies","volume":"292","author":"Gu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Dang, M., Wu, L., and Zhang, X. (2025). Structural insights and milestones in TDP-43 research: A comprehensive review of its pathological and therapeutic advances. Int. J. Biol. Macromol., 306.","DOI":"10.1016\/j.ijbiomac.2025.141677"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Montalbano, M., McAllen, S., Cascio, F.L., Sengupta, U., Garcia, S., Bhatt, N., Ellsworth, A., Heidelman, E.A., Johnson, O.D., and Doskocil, S. (2020). TDP-43 and Tau Oligomers in Alzheimer\u2019s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiol. Dis., 146.","DOI":"10.1016\/j.nbd.2020.105130"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlx099","article-title":"The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases","volume":"77","author":"Nelson","year":"2018","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Thomas, D.X., Bajaj, S., McRae-McKee, K., Hadjichrysanthou, C., Anderson, R.M., and Collinge, J. (2020). Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer\u2019s disease neuropathology. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71305-2"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000001831","article-title":"Multiple pathologies are common and related to dementia in the oldest-old: The 90 + Study","volume":"85","author":"Kawas","year":"2015","journal-title":"Neurology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.20203","article-title":"Clinicopathological correlates in frontotemporal dementia","volume":"56","author":"Hodges","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","article-title":"The evolution and pathology of frontotemporal dementia","volume":"128","author":"Kertesz","year":"2005","journal-title":"Brain"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/ana.20873","article-title":"Frontotemporal dementia: Clinicopathological correlations","volume":"59","author":"Forman","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-007-0236-3","article-title":"Frontotemporal lobar degeneration: Clinical and pathological relationships","volume":"114","author":"Snowden","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Torres, A.K., Jara, C., Olesen, M.A., and Tapia-Rojas, C. (2021). Pathologically phosphorylated tau at S396\/404 (PHF-1) is accumulated inside of hippocampal synaptic mitochondria of aged Wild-type mice. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-83910-w"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e2316175121","DOI":"10.1073\/pnas.2316175121","article-title":"Structures of AT8 and PHF1 phosphomimetic tau: Insights into the posttranslational modification code of tau aggregation","volume":"121","author":"Mammeri","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e14582","DOI":"10.1002\/alz.14582","article-title":"Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer\u2019s disease","volume":"21","author":"Wisse","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jalz.2016.09.015","article-title":"Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample","volume":"13","author":"Brenowitz","year":"2017","journal-title":"Alzheimers Dement."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5114\/fn.2016.60391","article-title":"Survival in the pre-senile dementia frontotemporal lobar degeneration with TDP-43 proteinopathy: Effects of genetic, demographic and neuropathological variables","volume":"54","author":"Armstrong","year":"2016","journal-title":"Folia Neuropathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia","volume":"140","author":"Perry","year":"2017","journal-title":"Brain"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40478-023-01621-x","article-title":"Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies","volume":"11","author":"Koga","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","article-title":"TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: Correlation with argyrophilic grains but not other concomitant pathologies","volume":"126","author":"Arnold","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/brain\/awm305","article-title":"Argyrophilic grain disease","volume":"131","author":"Ferrer","year":"2008","journal-title":"Brain"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jnen\/nlad042","article-title":"The frequency and distribution of TDP-43 pathology in argyrophilic grain disease","volume":"82","author":"Koga","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-008-0463-2","article-title":"Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease","volume":"117","author":"Fujishiro","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","article-title":"Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: A distinct clinicopathologic subtype","volume":"136","author":"Koga","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Sainouchi, M., Tada, M., Fitrah, Y.A., Hara, N., Tanaka, K., Idezuka, J., Aida, I., Nakajima, T., Miyashita, A., and Akazawa, K. (2022). Brain TDP-43 pathology in corticobasal degeneration: Topographical correlation with neuronal loss. Neuropathol. Appl. Neurobiol., 48.","DOI":"10.1111\/nan.12786"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/neup.12980","article-title":"An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently","volume":"45","author":"Tomenaga","year":"2025","journal-title":"Neuropathology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/neup.12723","article-title":"An autopsy case of corticobasal syndrome due to asymmetric degeneration of the motor cortex and substantia nigra with TDP-43 proteinopathy, associated with Alzheimer\u2019s disease pathology","volume":"41","author":"Tando","year":"2021","journal-title":"Neuropathology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.26438","article-title":"TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy","volume":"92","author":"Smirnov","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12264-018-0300-0","article-title":"Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy","volume":"35","author":"Zhang","year":"2019","journal-title":"Neurosci. Bull."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Glashutter, M., Wijesinghe, P., and Matsubara, J.A. (2025). TDP-43 as a potential retinal biomarker for neurodegenerative diseases. Front. Neurosci., 19.","DOI":"10.3389\/fnins.2025.1533045"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4132\/jptm.2019.03.14","article-title":"Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy","volume":"53","author":"Kim","year":"2019","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","article-title":"TDP-43 interacts with amyloid-beta, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease","volume":"11","author":"Shih","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/neup.12938","article-title":"Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer\u2019s disease: A case report spanning 16\u2009years of memory loss","volume":"44","author":"Carlos","year":"2024","journal-title":"Neuropathology"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Huang, W., Zhou, Y., Tu, L., Ba, Z., Huang, J., Huang, N., and Luo, Y. (2020). TDP-43: From Alzheimer\u2019s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy. Front. Mol. Neurosci., 13.","DOI":"10.3389\/fnmol.2020.00026"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Zhang, L., Chen, Y., Liu, M., Wang, Y., and Peng, G. (2020). TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy. Front. Aging Neurosci., 11.","DOI":"10.3389\/fnagi.2019.00376"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e14202","DOI":"10.1002\/alz.14202","article-title":"Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy","volume":"21","author":"Wolk","year":"2025","journal-title":"Alzheimers Dement."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ana.24388","article-title":"Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease","volume":"77","author":"Nag","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_102","first-page":"147","article-title":"TDP-43 in aging and Alzheimer\u2019s disease\u2014A review","volume":"4","author":"Wilson","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/bpa.12556","article-title":"Hippocampal sclerosis, hippocampal neuron loss patterns and TDP-43 in the aged population","volume":"28","author":"Hokkanen","year":"2018","journal-title":"Brain Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/brain\/awz224","article-title":"LATE to the PART-y","volume":"142","author":"Josephs","year":"2019","journal-title":"Brain"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Lin","year":"2007","journal-title":"Ann. Neurol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e13159","DOI":"10.1111\/bpa.13159","article-title":"TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer\u2019s disease","volume":"33","author":"Oltmer","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_109","first-page":"22","article-title":"Molecular fragment characteristics and distribution of tangle associated TDP-43 (TATs) and other TDP-43 lesions in Alzheimer\u2019s disease","volume":"4","author":"Josephs","year":"2023","journal-title":"Free Neuropathol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3233\/JAD-190866","article-title":"MRI Markers of Mixed Pathology and Cognitive Impairment in Multiethnic Asians","volume":"73","author":"Tan","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jnen\/nlad105","article-title":"Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old","volume":"83","author":"Carlos","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00401-008-0400-4","article-title":"Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease","volume":"116","author":"Hu","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1440-1789.2009.01017.x","article-title":"Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology","volume":"29","author":"Kadokura","year":"2009","journal-title":"Neuropathology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: Combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jnen\/nlad098","article-title":"Cognitive symptoms progress with limbic-predominant age-related TDP-43 encephalopathy stage and co-occurrence with Alzheimer disease","volume":"83","author":"Hiya","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_117","first-page":"e2027","article-title":"Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy","volume":"100","author":"Pudumjee","year":"2023","journal-title":"Neurology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1093\/brain\/awaa299","article-title":"Protein contributions to brain atrophy acceleration in Alzheimer\u2019s disease and primary age-related tauopathy","volume":"143","author":"Josephs","year":"2020","journal-title":"Brain"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3233\/JAD-191040","article-title":"Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer\u2019s Disease Neuropathological Changes","volume":"73","author":"Buciuc","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: A longitudinal retrospective study","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mds.22193","article-title":"Involvement of motor pathways in corticobasal syndrome detected by diffusion tensor tractography","volume":"24","author":"Boelmans","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/mds.23062","article-title":"Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer\u2019s disease","volume":"25","author":"Josephs","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_123","first-page":"66","article-title":"Corticobasal degeneration and corticobasal syndrome: A review","volume":"1","author":"Constantinides","year":"2019","journal-title":"Clin. Park. Relat. Disord."},{"key":"ref_124","first-page":"701-e52","article-title":"Corticobasal syndrome: Neuroimaging and neurophysiological advances","volume":"26","author":"Suppa","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0b013e3181d9edde","article-title":"Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia","volume":"74","author":"Whitwell","year":"2010","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","article-title":"Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: An unusual clinicopathologic variant of CBD","volume":"125","author":"Kouri","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mdc3.12284","article-title":"Misleading Imaging and Clinical Features in Pathology-Proven Corticobasal Degeneration","volume":"3","author":"Jacob","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.26809","article-title":"Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/13554794.2015.1041534","article-title":"Mixed tau and TDP-43 pathology in a patient with unclassifiable primary progressive aphasia","volume":"22","author":"Flanagan","year":"2016","journal-title":"Neurocase"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2024.04.002","article-title":"Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with abnormalities in white matter structural integrity and connectivity: An ex-vivo diffusion MRI and pathology investigation","volume":"140","author":"Tazwar","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neurobiolaging.2025.03.001","article-title":"Relation of Alzheimer\u2019s disease-related TDP-43 proteinopathy to metrics from diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI)","volume":"150","author":"Lavrova","year":"2025","journal-title":"Neurobiol. Aging"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cortex.2023.08.019","article-title":"Diffusion tensor imaging-based multi-fiber tracking reconstructions can regionally differentiate phonetic versus prosodic subtypes of progressive apraxia of speech","volume":"171","author":"Gatto","year":"2024","journal-title":"Cortex"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e16320","DOI":"10.1111\/ene.16320","article-title":"Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy","volume":"31","author":"Badihian","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"107272","DOI":"10.1016\/j.parkreldis.2025.107272","article-title":"Longitudinal assessment of white matter alterations in progressive supranuclear palsy variants using diffusion tractography","volume":"132","author":"Costa","year":"2025","journal-title":"Park. Relat. Disord."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/s41380-023-02215-8","article-title":"The use of neuroimaging techniques in the early and differential diagnosis of dementia","volume":"28","author":"Chouliaras","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/cjn.2024.31","article-title":"PET Imaging in Dementia: Mini-Review and Canadian Perspective for Clinical Use","volume":"52","author":"Juengling","year":"2025","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40035-024-00419-8","article-title":"In vivo diagnosis of TDP-43 proteinopathies: In search of biomarkers of clinical use","volume":"13","author":"Bascunana","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.2967\/jnumed.121.263194","article-title":"(18)F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J. Nucl. Med."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Bao, W., Xie, F., Zuo, C., Guan, Y., and Huang, Y.H. (2021). PET Neuroimaging of Alzheimer\u2019s Disease: Radiotracers and Their Utility in Clinical Research. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.624330"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Conte, M., De Feo, M.S., Sidrak, M.M.A., Corica, F., Gorica, J., Granese, G.M., Filippi, L., De Vincentis, G., and Frantellizzi, V. (2023). Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook. Diagnostics, 13.","DOI":"10.3390\/diagnostics13101682"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Jiao, F., Wang, M., Sun, X., Ju, Z., Lu, J., Wang, L., Jiang, J., and Zuo, C. (2023). Based on Tau PET Radiomics Analysis for the Classification of Alzheimer\u2019s Disease and Mild Cognitive Impairment. Brain Sci., 13.","DOI":"10.3390\/brainsci13020367"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11307-022-01779-1","article-title":"Head-to-Head Comparison of Tau-PET Radioligands for Imaging TDP-43 in Post-Mortem ALS Brain","volume":"25","author":"Knight","year":"2023","journal-title":"Mol. Imaging Biol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/alz.12878","article-title":"TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer\u2019s disease","volume":"19","author":"Carlos","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/jnnp-2017-316402","article-title":"[(18)F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia","volume":"89","author":"Cope","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s00259-016-3434-1","article-title":"Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis","volume":"43","author":"Pytel","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21678421.2023.2174881","article-title":"FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS","volume":"24","author":"Sennfalt","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/alz.13385","article-title":"FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI","volume":"20","author":"Caminiti","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1212\/WNL.0000000000009722","article-title":"Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy","volume":"95","author":"Buciuc","year":"2020","journal-title":"Neurology"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Tanaka, M., Diano, M., and Battaglia, S. (2023). Editorial: Insights into structural and functional organization of the brain: Evidence from neuroimaging and non-invasive brain stimulation techniques. Front. Psychiatry, 14.","DOI":"10.3389\/fpsyt.2023.1225755"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Di Fazio, C., Tamietto, M., Stanziano, M., Nigri, A., Scaliti, E., and Palermo, S. (2025). Cortico-Cortical Paired Associative Stimulation (ccPAS) in Ageing and Alzheimer\u2019s Disease: A Quali-Quantitative Approach to Potential Therapeutic Mechanisms and Applications. Brain Sci., 15.","DOI":"10.3390\/brainsci15030237"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Palermo, S., Di Fazio, C., Scaliti, E., Stanziano, M., Nigri, A., and Tamietto, M. (2025). Cortical excitability and the aging brain: Toward a biomarker of cognitive resilience. Front. Psychol., 16.","DOI":"10.3389\/fpsyg.2025.1542880"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Alongi, P., Laudicella, R., Panasiti, F., Stefano, A., Comelli, A., Giaccone, P., Arnone, A., Minutoli, F., Quartuccio, N., and Cupidi, C. (2022). Radiomics Analysis of Brain [(18)F]FDG PET\/CT to Predict Alzheimer\u2019s Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040933"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/7\/716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:04:03Z","timestamp":1760033043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/7\/716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":153,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["brainsci15070716"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15070716","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]}}}